• English
    • Deutsch
  • English 
    • English
    • Deutsch
  • Login
View Item 
  •   Home
  • Universität Ulm / Medizin
  • Publikationsnachweise
  • View Item
  •   Home
  • Universität Ulm / Medizin
  • Publikationsnachweise
  • View Item
JavaScript is disabled for your browser. Some features of this site may not work without it.

Therapie des diabetischen Makulaodems mit den VEGF- Inhibitoren Ranibizumab und Bevacizumab: Schlusse aus grundlegenden In- vitro- Untersuchungen

Erstveröffentlichung
2014
Authors
Lang, Gabrielle E.
Lang, G. K.
Deissler, H. L.
Wissenschaftlicher Artikel


Published in
Klinische Monatsblätter für Augenheilkunde ; 231 (2014), 5. - S. 527-534. - ISSN 0023-2165. - eISSN 1439-3999
Link to publication
https://dx.doi.org/10.1055/s-0033-1360360
Institutions
UKU. Klinik für Augenheilkunde
Subject headings
[Free subject headings]: VEGF | Ranibizumab | Bevacizumab | diabetisches Makulaodem | In-vitro-Studien | Retina | diabetic macular edema | in vitro studies | endothelial growth-factor | protein-kinase-c | retinal-pigment epithelium | macular edema | in-vitro | iris neovascularization | intravitreal injection | factor combinations | barrier breakdown | nonhuman primate
[DDC subject group]: DDC 610 / Medicine & health

Metadata
Show full item record

Policy | kiz service OPARU | Contact Us
Impressum | Privacy statement
 

 

Advanced Search

Browse

All of OPARUCommunities & CollectionsPersonsInstitutionsPublication typesUlm SerialsDewey Decimal ClassesEU projects UlmDFG projects UlmOther projects Ulm

My Account

LoginRegister

Statistics

View Usage Statistics

Policy | kiz service OPARU | Contact Us
Impressum | Privacy statement